318 related articles for article (PubMed ID: 35456629)
1. Mucoadhesive Nanocarriers as a Promising Strategy to Enhance Intracellular Delivery against Oral Cavity Carcinoma.
Pandey M; Choudhury H; Ying JNS; Ling JFS; Ting J; Ting JSS; Zhia Hwen IK; Suen HW; Samsul Kamar HS; Gorain B; Jain N; Mohd Amin MCI
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456629
[TBL] [Abstract][Full Text] [Related]
2. Lipid-Based Nanocarriers for Lymphatic Transportation.
Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery from the oral cavity: a focus on mucoadhesive buccal drug delivery systems.
Shinkar DM; Dhake AS; Setty CM
PDA J Pharm Sci Technol; 2012; 66(5):466-500. PubMed ID: 23035030
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
Cai Z; Wang Y; Zhu LJ; Liu ZQ
Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
[TBL] [Abstract][Full Text] [Related]
5. A novel versatile flow-donor chamber as biorelevant ex-vivo test assessing oral mucoadhesive formulations.
Gidvall S; Björklund S; Feiler A; Dahlström B; Rönn R; Engblom J; Valetti S
Eur J Pharm Sci; 2021 Nov; 166():105983. PubMed ID: 34461276
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
[TBL] [Abstract][Full Text] [Related]
7. Oral transmucosal drug delivery for pediatric use.
Lam JK; Xu Y; Worsley A; Wong IC
Adv Drug Deliv Rev; 2014 Jun; 73():50-62. PubMed ID: 23999459
[TBL] [Abstract][Full Text] [Related]
8. Palatal mucosa as a route for systemic drug delivery: A review.
Shakya P; Madhav NV; Shakya AK; Singh K
J Control Release; 2011 Apr; 151(1):2-9. PubMed ID: 21059376
[TBL] [Abstract][Full Text] [Related]
9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
10. Nasal route and drug delivery systems.
Türker S; Onur E; Ozer Y
Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
[TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive polymers for oral transmucosal drug delivery: a review.
Bagan J; Paderni C; Termine N; Campisi G; Lo Russo L; Compilato D; Di Fede O
Curr Pharm Des; 2012; 18(34):5497-514. PubMed ID: 22632395
[TBL] [Abstract][Full Text] [Related]
12. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.
Shreya AB; Raut SY; Managuli RS; Udupa N; Mutalik S
AAPS PharmSciTech; 2018 Dec; 20(1):15. PubMed ID: 30564942
[TBL] [Abstract][Full Text] [Related]
13. Nanoemulsions for "Nose-to-Brain" Drug Delivery.
Bonferoni MC; Rossi S; Sandri G; Ferrari F; Gavini E; Rassu G; Giunchedi P
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781585
[TBL] [Abstract][Full Text] [Related]
14. Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery.
Zacaron TM; Silva MLSE; Costa MP; Silva DME; Silva AC; Apolônio ACM; Fabri RL; Pittella F; Rocha HVA; Tavares GD
Polymers (Basel); 2023 Sep; 15(18):. PubMed ID: 37765701
[TBL] [Abstract][Full Text] [Related]
15. Beyond traditional therapy: Mucoadhesive polymers as a new frontier in oral cancer management.
Das S; Bhattacharya K; Blaker JJ; Singha NK; Mandal M
Biopolymers; 2023 Sep; 114(9):e23556. PubMed ID: 37341448
[TBL] [Abstract][Full Text] [Related]
16. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
Silva AC; Santos D; Ferreira D; Lopes CM
Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
[TBL] [Abstract][Full Text] [Related]
17. Potential of Liposomes for Enhancement of Oral Drug Absorption.
Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesion and Mechanical Assessment of Oral Films.
Alaei S; Omidian H
Eur J Pharm Sci; 2021 Apr; 159():105727. PubMed ID: 33484813
[TBL] [Abstract][Full Text] [Related]
19. Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems.
Xu Y; Shrestha N; Préat V; Beloqui A
J Control Release; 2020 Jun; 322():486-508. PubMed ID: 32276004
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit.
Mangla B; Javed S; Sultan MH; Ahsan W; Aggarwal G; Kohli K
Front Pharmacol; 2021; 12():757761. PubMed ID: 35087403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
